Literature DB >> 5560899

Destruction of chlorpromazine during absorption in the rat in vivo and in vitro.

S H Curry, A D'Mello, G P Mould.   

Abstract

1. Concentrations of total radioactivity in plasma of rats given intravenous and oral (35)S-chlorpromazine, were similar. Concentrations of unchanged drug, however, were lower after oral doses.2. Chlorpromazine circulated in solution through isolated loops of rat intestine was rapidly absorbed by the tissue. Measurements of glucose transport and histological examination indicated that the tissue was intact. In these in vitro experiments some of the chlorpromazine was converted to products, which together with unchanged drug, were partly retained in the intestinal wall and partly transferred to the serosal side of the tissue. Observations at three concentrations supported the hypothesis that transfer of unchanged drug occurred by passive diffusion.3. Conversion of chlorpromazine to metabolites in the intestine in vivo, would account for the differences in concentrations of chlorpromazine and total radio-activity in plasma after oral doses.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5560899      PMCID: PMC1665658          DOI: 10.1111/j.1476-5381.1971.tb07125.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  9 in total

1.  A preparation of surviving rat small intestine for the study of absorption.

Authors:  R B FISHER; D S PARSONS
Journal:  J Physiol       Date:  1949-12-15       Impact factor: 5.182

2.  Plasma protein binding of chlorpromazine.

Authors:  S H Curry
Journal:  J Pharm Pharmacol       Date:  1970-03       Impact factor: 3.765

3.  Studies of delayed-action medication. V. Plasma levels and urinary excretion of four different dosage forms of chlorpromazine.

Authors:  L E Hollister; S H Curry; J E Derr; S L Kanter
Journal:  Clin Pharmacol Ther       Date:  1970 Jan-Feb       Impact factor: 6.875

4.  Factors affecting chlorpromazine plasma levels in psychiatric patients.

Authors:  S H Curry; J M Davis; D S Janowsky; J H Marshall
Journal:  Arch Gen Psychiatry       Date:  1970-03

5.  The physiological disposition of chlorpromazine in the rat and dog.

Authors:  S H Curry; J E Derr; H M Maling
Journal:  Proc Soc Exp Biol Med       Date:  1970-05

6.  Destruction of chlorpromazine during absorption by rat intestine in vitro.

Authors:  S H Curry; A D'Mello; G P Mould
Journal:  Br J Pharmacol       Date:  1970-11       Impact factor: 8.739

7.  Influence of the route of administration on the area under the plasma concentration-time curve.

Authors:  P A Harris; S Riegelman
Journal:  J Pharm Sci       Date:  1969-01       Impact factor: 3.534

8.  Determination of nanogram quantities of chlorpromazine and some of its metabolites in plasma using gas-liquid chromatography with an electron capture detector.

Authors:  S H Curry
Journal:  Anal Chem       Date:  1968-07       Impact factor: 6.986

9.  Physicochemical and biochemical aspects of pharmacology.

Authors:  B B Brodie
Journal:  JAMA       Date:  1967-11-13       Impact factor: 56.272

  9 in total
  12 in total

1.  Proceedings: A microsomal oxidase system in rat intestinal mucosa.

Authors:  S H Curry; G P Mould
Journal:  Br J Pharmacol       Date:  1975-06       Impact factor: 8.739

2.  The significance of drug interactions in the evaluation of psychotropic drugs.

Authors:  R A Braithwaite
Journal:  Br J Clin Pharmacol       Date:  1976-02       Impact factor: 4.335

Review 3.  Plasma level monitoring of antipsychotic drugs.

Authors:  T B Cooper
Journal:  Clin Pharmacokinet       Date:  1978 Jan-Feb       Impact factor: 6.447

Review 4.  Pharmacokinetics of long-acting injectable neuroleptic drugs: clinical implications.

Authors:  S R Marder; J W Hubbard; T Van Putten; K K Midha
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

5.  Potentiation of the effects of chlorpromazine on exploration in the rat by a prior experience of the drug.

Authors:  S E File
Journal:  Psychopharmacologia       Date:  1973

6.  The sulfoxidation of fluphenazine in schizophrenic patients maintained on fluphenazine decanoate.

Authors:  K K Midha; J W Hubbard; S R Marder; E M Hawes; T Van Putten; G McKay; P R May
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

Review 7.  Influence of food on the bioavailability of drugs.

Authors:  A Melander
Journal:  Clin Pharmacokinet       Date:  1978 Sep-Oct       Impact factor: 6.447

8.  Drug metabolism by the gastrointestinal mucosa.

Authors:  C F George
Journal:  Clin Pharmacokinet       Date:  1981 Jul-Aug       Impact factor: 6.447

9.  Kinetics of fluphenazine after fluphenazine dihydrochloride, enanthate and decanoate administration to man.

Authors:  S H Curry; R Whelpton; P J de Schepper; S Vranckx; A A Schiff
Journal:  Br J Clin Pharmacol       Date:  1979-04       Impact factor: 4.335

10.  Pharmacokinetics of promethazine and its sulphoxide metabolite after intravenous and oral administration to man.

Authors:  G Taylor; J B Houston; J Shaffer; G Mawer
Journal:  Br J Clin Pharmacol       Date:  1983-03       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.